跳至主要内容
临床试验/NCT00026936
NCT00026936已完成2 期

A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning

National Cancer Institute (NCI)1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 1999年5月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
140
试验地点
1

研究概览

简要总结

The utility of PEREGRINE Monte Carlo calculations for radiation treatment planning in a clinical setting will be assessed by comparing results with other fully three-dimensional programs. ROB will investigate PEREGRINE for clinical use at NCI in collaboration with Lawrence Livermore National Laboratory (LLNL).

详细描述

The utility of PEREGRINE Monte Carlo calculations for radiation treatment planning in a clinical setting will be assessed by comparing results with other fully three-dimensional programs. ROB will investigate PEREGRINE for clinical use at NCI.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Patients with documented malignancy requiring standard radiotherapy OR patients with a benign condition for whom radiotherapy is indicated.

排除标准

  • •Documented connective tissue disease or Ataxia Telangiectasia.
  • •Cognitively impaired patients who cannot give informed consent.
  • •Other medical conditions deemed by the PI to make the patient ineligible.
  • •Patients requiring emergent radiotherapy.
  • •Patients who are not able to undergo a CT scan.

研究者

申办方类型
Nih

研究点 (1)

Loading locations...

相似试验